ArticleJournal of cancer research and clinical oncology2023

LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.

Wenjing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.